Automated calculation of point A coordinates for CT-based high-dose-rate brachytherapy of cervical cancer

被引:1
|
作者
Kang, Hyejoo [1 ]
Padilla, Laura [2 ]
Hasan, Yasmin [3 ]
Ai-Hallaq, Hania [3 ]
机构
[1] Loyola Med, Dept Radiat Oncol, Maywood, IL USA
[2] Virginia Commonwealth Univ Hlth Syst, Dept Radiat Oncol, Richmond, VA USA
[3] Univ Chicago, Dept Radiat & Cellular Oncol, 5758 S Maryland Ave MC 9006, Chicago, IL 60637 USA
关键词
brachytherapy; automation; dose calculation point; image-guided brachytherapy; cervical cancer; FAILURE MODES; EFFICIENCY; CARCINOMA; SOCIETY; RECOMMENDATIONS; VOLUME;
D O I
10.5114/jcb.2017.69397
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The goal is to develop a stand-alone application, which automatically and consistently computes the coordinates of the dose calculation point recommended by the American Brachytherapy Society (i.e., point A) based solely on the implanted applicator geometry for cervical cancer brachytherapy. Material and methods: The application calculates point A coordinates from the source dwell geometries in the computed tomography (CT) scans, and outputs the 3D coordinates in the left and right directions. The algorithm was tested on 34 CT scans of 7 patients treated with high-dose-rate (HDR) brachytherapy using tandem and ovoid applicators. A single experienced user retrospectively and manually inserted point A into each CT scan, whose coordinates were used as the "gold standard" for all comparisons. The gold standard was subtracted from the automatically calculated points, a second manual placement by the same experienced user, and the clinically used point coordinates inserted by multiple planners. Coordinate differences and corresponding variances were compared using nonparametric tests. Results: Automatically calculated, manually placed, and clinically used points agree with the gold standard to < 1 mm, 1 mm, 2 mm, respectively. When compared to the gold standard, the average and standard deviation of the 3D coordinate differences were 0.35 +/- 0.14 mm from automatically calculated points, 0.38 +/- 0.21 mm from the second manual placement, and 0.71 +/- 0.44 mm from the clinically used point coordinates. Both the mean and standard deviations of the 3D coordinate differences were statistically significantly different from the gold standard, when point A was placed by multiple users (p < 0.05) but not when placed repeatedly by a single user or when calculated automatically. There were no statistical differences in doses, which agree to within 1-2% on average for all three groups. Conclusions: The study demonstrates that the automated algorithm calculates point A coordinates consistently, while reducing inter-user variability. Point placement using the algorithm expedites the planning process and minimizes associated potential human errors.
引用
收藏
页码:354 / 358
页数:5
相关论文
共 50 条
  • [41] CORRELATION OF POINT B AND LYMPH NODE DOSE IN 3D-PLANNED HIGH-DOSE-RATE CERVICAL CANCER BRACHYTHERAPY
    Lee, Larissa J.
    Sadow, Cheryl A.
    Russell, Anthony
    Viswanathan, Akila N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : 803 - 809
  • [42] Can point doses predict volumetric dose to rectum and bladder: a CT-based planning study in high dose rate intracavitary brachytherapy of cervical carcinoma?
    Patil, V. M.
    Patel, F. D.
    Chakraborty, S.
    Oinam, A. S.
    Sharma, S. C.
    BRITISH JOURNAL OF RADIOLOGY, 2011, 84 (1001): : 441 - 448
  • [43] 3D CT-based high-dose-rate breast brachytherapy implants: Treatment planning and quality assurance
    Department of Human Oncology, University of Wisconsin, Madison, WI, United States
    不详
    1600, 1224-1228 (July 15, 2004):
  • [44] 3D CT-based high-dose-rate breast brachytherapy implants: Treatment planning and quality assurance
    Das, RK
    Patel, R
    Shah, H
    Odau, H
    Kuske, RR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (04): : 1224 - 1228
  • [45] Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer
    Toita, T
    Moromizato, H
    Ogawa, K
    Kakinohana, Y
    Maehama, T
    Kanazawa, K
    Murayama, S
    GYNECOLOGIC ONCOLOGY, 2005, 96 (03) : 665 - 670
  • [46] Local vaginal anesthesia during high-dose-rate intracavitary brachytherapy for cervical cancer
    Chen, HC
    Leung, SW
    Wang, CJ
    Sun, LM
    Fang, FM
    Huang, EY
    Wang, SJ
    Yang, CW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (03): : 541 - 544
  • [47] The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy
    Chen, SW
    Liang, JA
    Yang, SN
    Ko, HL
    Lin, FJ
    RADIOTHERAPY AND ONCOLOGY, 2003, 67 (01) : 69 - 76
  • [48] Posttraumatic Stress Disorder After High-Dose-Rate Brachytherapy for Cervical Cancer Reply
    Kirchheiner, Kathrin
    Czajka-Pepl, Agnieszka
    Ponocny-Seliger, Elisabeth
    Scharbert, Gisela
    Wetzel, Leonore
    Nout, Remi A.
    Sturdza, Alina
    Dimopoulos, Johannes C.
    Doerr, Wolfgang
    Poetter, Richard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (02): : 469 - 470
  • [49] High-dose-rate brachytherapy as monotherapy for prostate cancer
    Demanes, D. Jeffrey
    Ghilezan, Michel I.
    BRACHYTHERAPY, 2014, 13 (06) : 529 - 541
  • [50] Cervical cancer outcomes in the high-dose-rate brachytherapy era: A single institution experience
    Alyamani, N.
    Bhattacharya, G.
    Samant, R.
    E, C.
    Le, T.
    Lupe, K.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S977 - S977